Compounds with A2BAR agonist activity or A1AR and A3AR antagonist activity, and agonists of P2Y2R or antagonists of P2Y13R, P2Y14R, P2X3R, P2X4R, and P2X7R should be beneficial for the treatment of asthma. The gene discussed is P2RX4; the disease is asthma.